Reducing Cardiovascular Risk in People w/Type 2 Diabetes

If you’ve recently been diagnosed with Type 2 Diabetes and a significant cardiovascular risk you may want to review the 2017 guidelines on reducing cardiovascular risk  from the American Diabetes Association.

You may also want to review some of the evidence on Statin use and the development of Type 2 Diabetes from the British Journal of Clinical Pharmacology, with comments by the study author, Fariba Ahmadizar and Robert Eckel, MD professor of medicine and director of the Lipid Clinic at the University of Colorado Hospital. One of the items of note from that study was that overweight and obese people had  ah igher risk of developing Type 2 Diabetes associated with Statin use.

It’s important to understand that Statins lower cholesterol by blocking the production an enzyme in the liver that helps make cholesterol. A Patients Place also recommends reading the 2019 article by D. Schade, MD, on the common misconceptions of prescribing Statins to reduce cardiovascular disease in The American Journal of Medicine.

 

Leave a Reply